In an older adult with suspected pernicious anemia, macrocytic anemia, positive anti‑intrinsic factor antibodies, and gastrointestinal alarm features, should an upper gastrointestinal endoscopy be performed?

Yes, upper endoscopy is strongly indicated in this patient.

In an older adult with suspected pernicious anemia, positive anti-intrinsic factor antibodies, and gastrointestinal alarm features, upper endoscopy should be performed to confirm corpus-predominant atrophic gastritis, risk-stratify for gastric neoplasia, and rule out gastric neuroendocrine tumors or adenocarcinoma 1.

Primary Rationale

The 2021 AGA guidelines explicitly state that patients with a new diagnosis of pernicious anemia who have not had a recent endoscopy should undergo endoscopy with topographical biopsies 1. This recommendation is driven by three critical outcomes affecting morbidity and mortality:

1. Gastric cancer risk: Pernicious anemia represents late-stage autoimmune gastritis with established corpus-predominant atrophy, placing patients at significantly elevated risk for gastric adenocarcinoma 1

2. Neuroendocrine tumor detection: Type 1 gastric neuroendocrine tumors occur in autoimmune gastritis patients and require endoscopic surveillance 1. Research shows that 6 of 34 patients (18%) with pernicious anemia had gastric neuroendocrine tumors, and 1 had adenocarcinoma 2

3. Risk stratification: Histologic confirmation and extent of atrophy determine surveillance intervals and guide management 1

The Presence of Alarm Features Makes This Urgent

While the guidelines recommend endoscopy for pernicious anemia regardless of symptoms, gastrointestinal alarm features in this context demand immediate evaluation. The combination of macrocytic anemia with GI alarm symptoms substantially increases pre-test probability for serious pathology including malignancy 3.

Technical Approach to Endoscopy

When performing endoscopy in this patient, the endoscopist should 1:

• Assess extent of atrophic changes endoscopically (pallor, visible vasculature, loss of gastric folds, light blue crests, white opaque fields)
• Obtain topographical biopsies from body and antrum/incisura in separately labeled jars at minimum
• Take targeted biopsies from any additional mucosal abnormalities
• Screen for H. pylori infection (present in up to 66.7% of IDA patients with autoimmune gastritis) 4

Important Caveats

Do not delay endoscopy to obtain additional serologic testing. The patient already has positive anti-intrinsic factor antibodies (73% sensitivity, 100% specificity for pernicious anemia) 5, which is sufficient to proceed with endoscopy.

The macrocytic anemia itself does not contraindicate endoscopy. While severe B12 deficiency can cause pseudo-hemolytic features 6, 7, endoscopy remains safe and necessary for definitive diagnosis and cancer screening.

Post-Endoscopy Management

After endoscopy confirms autoimmune gastritis 1:

• Initiate B12 replacement therapy (intramuscular initially given malabsorption)
• Evaluate for iron deficiency (common comorbidity requiring separate supplementation)
• Screen for autoimmune thyroid disease (present in 40% of pernicious anemia patients) 5
• Establish surveillance endoscopy schedule: every 3 years for advanced atrophic gastritis, every 1-2 years if neuroendocrine tumors detected 1

The bottom line: This patient requires upper endoscopy both to confirm the diagnosis of pernicious anemia with histologic evidence and to exclude prevalent gastric neoplasia that would significantly impact mortality. The presence of alarm features makes this evaluation even more urgent and non-negotiable.